Back
Sarepta Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
46
SRPT
Sarepta Therapeutics
Last Price:
$19.18
Seasonality Move:
20.21%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
Sarepta Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.01 | Buy |
20-day SMA: | 22.52 | Sell |
50-day SMA: | 34.92 | Sell |
200-day SMA: | 89.82 | Sell |
8-day EMA: | 7.59 | Buy |
20-day EMA: | 3.48 | Buy |
50-day EMA: | 1.48 | Buy |
200-day EMA: | 0.38 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.72 | Buy |
Relative Strength Index (14 RSI): | 30.63 | Sell |
Chaikin Money Flow: | 477026 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.2 - 35.86) | Sell |
Bollinger Bands (100): | (28.39 - 87.43) | Sell |
Sarepta Therapeutics Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 19.37 while SRPT 8-day simple moving average is 18.01, which is a Buy signal.
-
The stock price of SRPT is 19.37 while Sarepta Therapeutics 20-day SMA is 22.52, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 34.92 while SRPT share price is 19.37, making it a Sell technically.
-
SRPT stock price is 19.37 and Sarepta Therapeutics 200-day simple moving average is 89.82, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a SellThe current Sarepta Therapeutics [SRPT] share price is $19.37. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
1.9B
Price in USD:
19.37
Share Volume:
4M
Sarepta Therapeutics 52-Week Range
52-Week High:
154.13
52-Week Low:
16.88
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 19.37 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 19.37 while SRPT 8-day exponential moving average is 7.59, which is a Buy signal.
-
The stock price of SRPT is 19.37 while Sarepta Therapeutics 20-day EMA is 3.48, which makes it a Buy.
-
Sarepta Therapeutics 50-day exponential moving average is 1.48 while SRPT share price is 19.37, making it a Buy technically.
-
SRPT stock price is 19.37 and Sarepta Therapeutics 200-day simple moving average is 0.38, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.75 per share, a decrease this year of $5.88 per share, and an increase next year of $5.33 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is 2.72, suggesting Sarepta Therapeutics is a Buy
-
Sarepta Therapeutics Relative Strength Index (RSI) is 30.63, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (16.2 - 35.86), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (28.39 - 87.43), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.